Israel H - Search Results

1

The use of gabapentin in chronic cluster headache patients refractory to first-line therapy.

Schuh-Hofer S, Israel H, Neeb L, Reuter U, Arnold G. Schuh-Hofer S, et al. Among authors: israel h. Eur J Neurol. 2007 Jun;14(6):694-6. doi: 10.1111/j.1468-1331.2007.01738.x. Eur J Neurol. 2007. PMID: 17539953 Clinical Trial.

2

Efficacy of lisinopril in migraine prophylaxis--an open label study.

Schuh-Hofer S, Flach U, Meisel A, Israel H, Reuter U, Arnold G. Schuh-Hofer S, et al. Among authors: israel h. Eur J Neurol. 2007 Jun;14(6):701-3. doi: 10.1111/j.1468-1331.2007.01764.x. Eur J Neurol. 2007. PMID: 17539955 Clinical Trial.

3

Erenumab and galcanezumab in chronic migraine prevention: effects after treatment termination.

Raffaelli B, Mussetto V, Israel H, Neeb L, Reuter U. Raffaelli B, et al. Among authors: israel h. J Headache Pain. 2019 Jun 3;20(1):66. doi: 10.1186/s10194-019-1018-8. J Headache Pain. 2019. PMID: 31159727 Free PMC article. Clinical Trial.

4

Corticosteroids alter CGRP and melatonin release in cluster headache episodes.

Neeb L, Anders L, Euskirchen P, Hoffmann J, Israel H, Reuter U. Neeb L, et al. Among authors: israel h. Cephalalgia. 2015 Apr;35(4):317-26. doi: 10.1177/0333102414539057. Epub 2014 Jun 23. Cephalalgia. 2015. PMID: 24958681 Clinical Trial.

5

The use of radiolabelled human serum albumin and SPECT/MRI co-registration to study inflammation in the cavernous sinus of cluster headache patients.

Schuh-Hofer S, Richter M, Israel H, Geworski L, Villringer A, Munz DL, Arnold G. Schuh-Hofer S, et al. Among authors: israel h. Cephalalgia. 2006 Sep;26(9):1115-22. doi: 10.1111/j.1468-2982.2006.01170.x. Cephalalgia. 2006. PMID: 16919062 Clinical Trial.

6

Increased serotonin transporter availability in the brainstem of migraineurs.

Schuh-Hofer S, Richter M, Geworski L, Villringer A, Israel H, Wenzel R, Munz DL, Arnold G. Schuh-Hofer S, et al. Among authors: israel h. J Neurol. 2007 Jun;254(6):789-96. doi: 10.1007/s00415-006-0444-0. Epub 2007 Mar 12. J Neurol. 2007. PMID: 17351723

7

The pharmacological profile and clinical prospects of the oral 5-HT1F receptor agonist lasmiditan in the acute treatment of migraine.

Reuter U, Israel H, Neeb L. Reuter U, et al. Among authors: israel h. Ther Adv Neurol Disord. 2015 Jan;8(1):46-54. doi: 10.1177/1756285614562419. Ther Adv Neurol Disord. 2015. PMID: 25584073 Free PMC article. Review.

8

The safety and efficacy of the 5-HT 1F receptor agonist lasmiditan in the acute treatment of migraine.

Raffaelli B, Israel H, Neeb L, Reuter U. Raffaelli B, et al. Among authors: israel h. Expert Opin Pharmacother. 2017 Sep;18(13):1409-1415. doi: 10.1080/14656566.2017.1361406. Epub 2017 Aug 10. Expert Opin Pharmacother. 2017. PMID: 28749698 Review.

9

CGRP Monoclonal Antibodies for the Preventative Treatment of Migraine.

Israel H, Neeb L, Reuter U. Israel H, et al. Curr Pain Headache Rep. 2018 Apr 6;22(5):38. doi: 10.1007/s11916-018-0686-4. Curr Pain Headache Rep. 2018. PMID: 29623520 Review.

10

Intracisternal injection of inflammatory soup activates the trigeminal nerve system.

Hoffmann J, Neeb L, Israel H, Dannenberg F, Triebe F, Dirnagl U, Reuter U. Hoffmann J, et al. Among authors: israel h. Cephalalgia. 2009 Nov;29(11):1212-7. doi: 10.1111/j.1468-2982.2009.01858.x. Epub 2009 Apr 9. Cephalalgia. 2009. PMID: 19558535

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

349 results

Search Page

Filters